Assessing Reasons for Treatment and Treatment Type in Females with Bleeding Disorders
Click here to read Presented at ASH in San Diego 2023. Dr. Danielle Nance of FTFW was an author. It argues for prophylaxis for women with ABRs of 2 or...
Click here to read Presented at ASH in San Diego 2023. Dr. Danielle Nance of FTFW was an author. It argues for prophylaxis for women with ABRs of 2 or...
Click here to read Women and girls affected by haemophilia (WGH) are at an increased risk of bleeding. Furthermore, lack of recognition and misidentification is an ongoing issue.
Read More Here Annual report with excellent worldwide data. Page 45 contains interesting and compelling data on bleeding among women.
Read More Here From abstract: In 2004, 766 questionnaires were sent, and 546 women responded (80%). Of these, 274 were carriers of hemophilia A or B. The median clotting factor...
Read More Here The findings of the B-HERO-S study reveal potential unmet needs of some patients with mild-moderate hemophilia B, and the results may be leveraged to inform patient outreach...
Click here to view the Algorithm for the Diagnosis and Management of FVIII Variants in People with the Potential to Menstruate